Description

GW-501516 ( Cardarine) 15MG Pellets

ℹ️ What is GW-501516?

• Developed in the 1990s by GlaxoSmithKline and Ligand Pharmaceuticals.

• It is a selective agonist of the PPARδ receptor (Peroxisome Proliferator-Activated Receptor delta).

• Often sold as a “research chemical”, sometimes abused in sports/bodybuilding for its effects on endurance and fat metabolism.

⚙️ Operation

• Activates PPARδ → stimulates fat burning and increases endurance.

• May lead to a shift in energy metabolism from glucose to fatty acids.

• Considered by some to be “exercise mimetic” because it mimics effects of endurance training.

🧪 Usage & status

• Never approved as medicine.

• Clinical studies were discontinued after evidence in animal studies showed that GW-501516 may promote tumour growth.

• Has been on the WADA doping list (banned in sport).

⚠️ Risks

• Potential carcinogenic effects (seen in laboratory animals with prolonged use).

• Unknown safety in humans, no official dose or approved application.

• Usually used as research chemical sold → risk of impurity and wrong dosage.

  🏷️ Product: GW-501516 - “Cardarine”

  Shape: Powder, capsules or tablets (variable by provider)
  Strength: Often offered in doses of 5-20 mg per capsule/tablet
  Usage: Sold exclusively as a research chemical - not intended for consumption or medical use ⚠️

  ---

  📋 Features

  • Fabric type: Selective PPARδ agonist

  • Molecular formula: C₂₁H₁₈F₃NO₃S₂

  • Molecular weight: approx. 453.5 g/mol

  • CAS number: 317318-70-0

  ---

  🔬 Application (research)

  • Used in research on fat metabolism, insulin sensitivity and endurance.

  • Known as “exercise mimetic” because it can mimic effects of endurance training.

  ---

  ⚠️ Important warning

  • Not approved as a medicine.

  • In animal studies associated with increased risk of tumours.

  • Banned since 2009 by WADA in sports.

  • Usually offered for laboratory research and not for human use.